论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Wei YP, Ma L, Zhang L, Xu X
Received 19 June 2017
Accepted for publication 3 August 2017
Published 25 September 2017 Volume 2017:12 Pages 7039—7051
DOI https://doi.org/10.2147/IJN.S144322
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Thiruganesh Ramasamy
Peer reviewer comments 3
Editor who approved publication: Professor Dongwoo Khang
Abstract: An effective drug delivery system requires efficient drug uptake and
release inside cancer cells. Here, we report a novel drug delivery system, in
which paclitaxel (PTX) interacts with a novel cell penetrating peptide (CPP)
through noncovalent interaction designed based on molecular simulations. This
CPP/PTX complex confers high efficiency in delivering PTX into cancer cells not
by endocytosis but by an energy-independent pathway. Once inside cells, the
noncovalent interaction between PTX and the CPP may allow fast release of PTX
within cells due to the direct translocation of CPP/PTX. This drug delivery system
exhibits strong capacity for inhibition of tumor growth and offers a new avenue
for the development of advanced drug delivery systems for anticancer therapy.
Keywords: paclitaxel,
drug delivery, cell penetrating peptide, anticancer therapy, molecular simulations
